HEALTH PROTECTION AGENCY

ERWINASE

PHARMACEUTICAL COMPOSITIONS AND PREPARATIONS, NAMELY, INJECTABLE PHARMACEUTICAL COMPOSITIONS COMPRISING COMPOUNDS HAVING ASPARAGINASE ACTIVITY;

HEALTH PROTECTION AGENCY

educational research; educational services, namely, conducting programes, lectures, classes, workshops, seminars, exercises and practicals in the fields of laboratory and clinical techniques, public health, epidemiology, immunology, modeling the epidemiology of infectious diseases and the effectiveness of control measures including immunization, and emergency planning and preparedness;downloadable on-line electronic publications in the nature of reports, annual reports, directories, scientific papers, journals, advisory and guidance documents, leaflets, fact sheets, catalogues, statistical surveys, corporate literature, press releases in the field of public health, microbiology, emergency planning and electro magnetic radiation;[ pharmaceutical and veterinary preparations and substances, namely, pharmaceuticals, biopharmaceuticals and vaccines for use in oncology and in connection with infectious diseases and central nervous system diseases; diagnostic preparations and reagents for clinical or medical laboratory use, all for in vivo use; diagnostic chemical preparations, enzymes and reagents for medical use for use in diagnostic assays for the detection of infectious diseases and for clinical or medical use including checking blood type and tissue samples; media for bacteriological cultures; reference cultures of micro-organisms in the nature of bacteria, viruses, fungi and compounds thereof, including DNA, proteins and other cell components for medical, diagnostic and veterinary use ];Color is not claimed as a feature of the mark.;[ chemical products and substances for in vitro use, namely, chemical additives for use in the manufacture of pharmaceuticals ];[ medical services; veterinary services; health care; hospitals and medical clinics; emergency medical assistance; nursing care ];AGENCY;medical and scientific research services relating to infectious diseases, threats to public health, bioterrorism, microbiology; medical and scientific research regarding clinical trial studies on new vaccine candidates; research and product development services; consultancy services in the field of research and product development, dissemination of information in the field of research and product development; all of the above relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, immunology, pharmacology and health matters;

HPA

educational research; educational services, namely, conducting programs, lectures, classes, workshops, seminars, exercises and practicals in the fields of laboratory and clinical techniques, public health, epidemiology, immunology, modeling the epidemiology of infectious diseases and the effectiveness of control measures including immunization, and emergency planning and preparedness;downloadable on-line electronic publications in the nature of reports, annual reports, directories, scientific papers, journals, advisory and guidance documents, leaflets, fact sheets, catalogues, statistical surveys, corporate literature, press releases in the field of public health, microbiology, emergency planning and electro magnetic radiation;[ veterinary preparations and substances, namely, vaccines for use in oncology and in connection with infectious diseases and central nervous system diseases; diagnostic preparations and reagents for clinical or medical laboratory use, all for in vivo use; diagnostic chemical preparations, enzymes and reagents for medical use for use in diagnostic assays for the detection of infectious diseases and for clinical or medical use including checking blood type and tissue samples; media for bacteriological cultures; reference cultures of micro-organisms in the nature of bacteria, viruses, fungi and compounds thereof, including DNA, proteins and other cell components for medical, diagnostic and veterinary use ];HEALTH PROTECTION AGENCY;[ chemical products and substances for in vitro use, namely, chemical additives for use in the manufacture of pharmaceuticals ];medical and scientific research services relating to infectious diseases, threats to public health, bioterrorism, microbiology; medical and scientific research regarding clinical trial studies on new vaccine candidates; research and product development services; consultancy services in the field of research and product development, dissemination of information in the field of research and product development; all of the above relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, immunology and health matters;

IMBA

Providing of training in the fields of internal dosimetry and the use of software for internal dosimetry; arranging and conducting of training courses in the fields of internal dosimetry and the use of software for internal dosimetry; workshops and seminars in the fields of internal dosimetry and the use of software for internal dosimetry; provision of degree courses, namely, providing continuing professional education courses in the fields of internal dosimetry and the use of software for internal dosimetry;Computer software for dosimetry, namely, for calculation of radiation dose and risks from radionuclides incorporated inside human body; computer software for estimating intakes of radiation doses and calculating internal radiation doses; computer software for identifying the doses of gases or radiation breathed in or ingested by a person;In the statement, line 24, 06-04-2020 should be deleted, and 10-27-2010 should be inserted;Design and development of computer software; maintenance and updating of computer software;